Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Collegium Pharmaceutical, Inc. (COLL : NSDQ)
 
 • Company Description   
Collegium Pharmaceutical Inc. is a specialty pharmaceutical company. It develops and commercializes prescription and over-the-counter pharmaceuticals for the treatment of central nervous system, respiratory and skin related disorders. The Company's product candidate consists of COL-195, COL-196, COL-171, COL-003 and COL-172 which are in different clinical trial. It developed a formulation platform technology, DETERx, for the treatment of chronic pain. Collegium Pharmaceutical Inc. is based in CUMBERLAND, United States.

Number of Employees: 357

 
 • Price / Volume Information   
Yesterday's Closing Price: $42.30 Daily Weekly Monthly
20 Day Moving Average: 414,440 shares
Shares Outstanding: 31.50 (millions)
Market Capitalization: $1,332.53 (millions)
Beta: 0.61
52 Week High: $43.06
52 Week Low: $23.23
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 27.37% 27.49%
12 Week 13.83% 9.43%
Year To Date 47.64% 24.21%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
100 Technology Center Drive
-
Stoughton,MA 02072
USA		 ph: 781-713-3699
fax: -		 ir@collegiumpharma.com http://www.collegiumpharma.com
 
 • General Corporate Information   
Officers
Vikram Karnani - Chief Executive Officer and President
Michael T. Heffernan - Chairman
Colleen Tupper - Executive Vice President and Chief Financial Offic
Rita Balice-Gordon - Director
Garen G. Bohlin - Director

Peer Information
Collegium Pharmaceutical, Inc. (GSAC)
Collegium Pharmaceutical, Inc. (CASI)
Collegium Pharmaceutical, Inc. (ALCD.)
Collegium Pharmaceutical, Inc. (OMNN)
Collegium Pharmaceutical, Inc. (CGPI.)
Collegium Pharmaceutical, Inc. (CATX)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-DRUGS
Sector: Medical
CUSIP: 19459J104
SIC: 2834
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 09/01/25
Next Expected EPS Date: 02/26/26
Share - Related Items
Shares Outstanding: 31.50
Most Recent Split Date: (:1)
Beta: 0.61
Market Capitalization: $1,332.53 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $1.89 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $6.27 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio: 0.00
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 02/26/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 6.74
Trailing 12 Months: 6.62
PEG Ratio: -
Price Ratios
Price/Book: 4.85
Price/Cash Flow: 3.43
Price / Sales: 1.76
EPS Growth
vs. Year Ago Period: 39.19%
vs. Previous Quarter: 40.14%
Sales Growth
vs. Year Ago Period: 31.42%
vs. Previous Quarter: 11.36%
ROE
09/30/25 - 102.03
06/30/25 - 97.28
03/31/25 - 99.08
ROA
09/30/25 - 15.24
06/30/25 - 13.87
03/31/25 - 15.14
Current Ratio
09/30/25 - 1.54
06/30/25 - 1.18
03/31/25 - 1.08
Quick Ratio
09/30/25 - -
06/30/25 - 1.10
03/31/25 - 1.01
Operating Margin
09/30/25 - 32.69
06/30/25 - 31.98
03/31/25 - 34.09
Net Margin
09/30/25 - 7.72
06/30/25 - 5.13
03/31/25 - 6.61
Pre-Tax Margin
09/30/25 - 10.68
06/30/25 - 7.50
03/31/25 - 9.80
Book Value
09/30/25 - 8.72
06/30/25 - 7.23
03/31/25 - 7.30
Inventory Turnover
09/30/25 - 8.70
06/30/25 - 8.22
03/31/25 - 8.11
Debt-to-Equity
09/30/25 - 2.94
06/30/25 - 3.27
03/31/25 - 3.30
Debt-to-Capital
09/30/25 - 74.62
06/30/25 - 76.56
03/31/25 - 76.73
 

Powered by Zacks Investment Research ©